Posted on :Thursday , 4th December 2014
Pharco Pharmaceuticals has entered into an exclusive license agreement to develop and commercialize Presidio’s clinical stage hepatitis C virus (HCV) NS5A inhibitor PPI-668 in Kenya.
Posted on :Wednesday , 19th November 2014
A Global Pharmaceutical firm on Friday launched a new anti malaria drug formulation into the Kenyan market that is aimed at increasing adherence to the medication.
Posted on :Friday , 14th November 2014 In the follow up of the recent launch of mobile health platforms in Nigeria healthcare. Airtel Nigeria is forming an alliance with an Indian outfit: Apollo Hospitals to enhance health care in Nigeria via telemedicine service. The telemedicine service will be available. . . Posted on :Friday , 31st October 2014 Merck, a leading company for innovative and top-quality high-tech products in the pharmaceutical, chemical and life-science sectors, announced on Thursday the signature of a memorandum of understanding with Posted on :Friday , 31st October 2014 Private equity firm Catalyst Principal Partners has bought a stake in Mimosa Pharmacy, a retail drugs store chain, in the first local investment by the investor.Airtel and Apollo Hospitals introduce Telemedicine to Nigeria Healthcare
Merck KGaA : forms partnership with Kenya medical research institute
Private equity firm Catalyst buys stake in Mimosa Pharmacy
Expogroup is a full service exhibition organiser with over 28 years experience in International trade exhibitions. Our current portfolio includes 28 annual exhibitions from a diverse range of industries being held across the Middle East & Africa.
EXPOGROUP © 1996 - 2025 | Privacy policy